PRESS RELEASE published on 10/09/2024 at 09:02, 5 months 28 days ago Original-Research: Nynomic AG (von NuWays AG): Buy Research update on Nynomic AG by NuWays AG reveals FY24 guidance cut due to order delays, with expected rebound in FY25 and strong mid-term prospects Mid-term Prospects Research Update FY24 Guidance Nynomic AG Order Delays
PRESS RELEASE published on 09/06/2024 at 12:06, 7 months ago Original-Research: Nynomic AG (von Montega AG): Kaufen Montega AG stuft Nynomic AG hoch mit Kaufempfehlung und 46,00 EUR Kursziel. Nynomic erwartet Rückkehr zu zweistelligem Wachstum 2025. Positive Cashflow-Entwicklung und vielversprechende Produktpipeline Montega AG Kaufempfehlung Cashflow Nynomic AG Wachstum
BRIEF published on 08/21/2024 at 09:06, 7 months 16 days ago NuWays AG Research Recommends Nynomic AG as BUY EBIT Margin NuWays AG Nynomic AG Q2 Sales FY25 Growth
BRIEF published on 08/21/2024 at 09:06, 7 months 16 days ago NuWays AG Research recommande Nynomic AG comme ACHETEUR NuWays AG Marge EBIT Ventes Du Deuxième Trimestre Nynomic SA Croissance De L'exercice 25
PRESS RELEASE published on 08/21/2024 at 09:01, 7 months 16 days ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG (DE000A0MSN11) updated research by NuWays AG recommends a BUY, with improving margins despite weak sales. Anticipated growth in FY25, favorable margin development, and accelerating growth from FY25 onwards Buy Recommendation NuWays AG Research Nynomic AG FY25 Growth
PRESS RELEASE published on 08/19/2024 at 18:31, 7 months 18 days ago Original-Research: Nynomic AG (von Montega AG): Kaufen Montega AG stuft Nynomic AG auf Kaufen mit Kursziel 46,00 EUR herab und prognostiziert moderates Wachstum in Q2 trotz Herausforderungen; Details in der Research-Studie Montega AG Kursziel Nynomic AG Wachstum Kaufen
PRESS RELEASE published on 05/10/2024 at 16:16, 10 months 27 days ago Original-Research: Nynomic AG (von Montega AG): Kaufen Montega AG stuft Nynomic AG hoch: Kaufempfehlung mit Kursziel 47,00 EUR und positivem Ausblick auf starke zweite Jahreshälfte Montega AG Kaufempfehlung Nynomic AG Q1-Zahlen M&A-Newsflow
BRIEF published on 05/10/2024 at 09:11, 10 months 27 days ago Nynomic AG Commences FY24 with Promising Growth Acquisitions Buy Recommendation Nynomic AG Financial Growth FY24 Forecasts
BRIEF published on 05/10/2024 at 09:11, 10 months 27 days ago Nynomic AG démarre l'exercice 24 avec une croissance prometteuse Croissance Financière Acquisitions Recommandation D'achat Nynomic AG Prévisions FY24
PRESS RELEASE published on 05/10/2024 at 09:06, 10 months 27 days ago Original-Research: Nynomic AG (von NuWays AG): Kaufen Nynomic AG shows promising performance in FY24 with order intake growth and solid Q1 results. Analysts recommend buying with a target price of EUR 52. Learn more in the research report Nynomic AG Recommendation Q1 Results Order Intake Growth FY24 Performance
Published on 04/07/2025 at 00:05, 7 hours 21 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 22 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 25 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 13 hours 5 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 16 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 25 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 25 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 13 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
